Search

Documento · Da admin admin Alle 5 dic 19, 23:31

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 8 dic 19, 04:14

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 8 dic 19, 03:27

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 7 dic 19, 01:36

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 01:22

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 7 dic 19, 01:25

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 23:22

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 21:51

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 23:42

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 02:17

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 23:33

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 23:34

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 16:40

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 7 dic 19, 00:04

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 16:29

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 23:15

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 16:44

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 09:20

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 00:18

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 21:56

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 23:23

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 23:33

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 09:41

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 7 dic 19, 11:14

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 09:37

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 09:07

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 00:06

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 01:16

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 8 dic 19, 04:08

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 16:25

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 23:11

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 7 dic 19, 11:05

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 6 dic 19, 23:50

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 09:00

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 5 dic 19, 23:15

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Documento · Da admin admin Alle 8 dic 19, 00:56

Come è la qualità dell’informazione sul controllo non farmacologico della colesterolemia nel nostro Paese? • Gli acidi grassi omega-3, secondo molti messaggi pubblicitari, abbassano la ...

Documento · Da Edoardo Di Matteo Alle 30 gen 26, 14:57

Anno di riferimento del Pagamento Trimestre Categoria di spesa Tipologia di spesa Importo Beneficiario 2025 IV uscite correnti Acquisto di beni e di servizi 489,00...

Documento · Da Edoardo Di Matteo Alle 24 lug 25, 16:06

Anno di riferimento del Pagamento Trimestre Categoria di spesa Tipologia di spesa Importo Beneficiario 2025 2 Uscite c/capitale Investimenti in beni materiali 59.780,00...

Documento · Da Stefano Pesarin Alle 17 ott 25, 10:38

Anno di riferimento del Pagamento Trimestre Categoria di spesa Tipologia di spesa Importo Beneficiario 2025 3 uscite correnti Contributi in conto esercizio 9.116.104,25 ...

Contenuto Web · Da sandra salinetti Alle 13 nov 19, 01:00

Rapporti ISTISAN. Results of the proficiency test on plant protection products in 2019.

Documento · Da admin admin Alle 6 dic 19, 23:58

Omega Congressi di Alessandra Pantanon Omemega Cong ssandra Panta Convegno Internazionale IL DISTURBO DELLA CONDOTTA IN ETA’ EVOLUTIVA R o m a 1 8 G i u g n o 2 0 1 0 Casa La Salle -...

Documento · Da admin admin Alle 6 dic 19, 01:01

Omega Congressi di Alessandra Pantanon Omemega Cong ssandra Panta Convegno Internazionale IL DISTURBO DELLA CONDOTTA IN ETA’ EVOLUTIVA R o m a 1 8 G i u g n o 2 0 1 0 Casa La Salle -...

Documento · Da admin admin Alle 6 dic 19, 21:05

Omega Congressi di Alessandra Pantanon Omemega Cong ssandra Panta Convegno Internazionale IL DISTURBO DELLA CONDOTTA IN ETA’ EVOLUTIVA R o m a 1 8 G i u g n o 2 0 1 0 Casa La Salle -...

Documento · Da Giovanna Morini Alle 6 nov 24, 08:56

Fedele, Paola Fenzi, Diana Gazzani, Marta Gironda, Antonella Laiti, Eleonora Moretti...Pucci, Andrea Scatena, Enrico Subicini, Laura Trombi, Elisa Valenti ASL Umbria 2:...

Documento · Da Giovanna Morini Alle 6 nov 24, 08:58

Fedele, Paola Fenzi, Diana Gazzani, Marta Gironda, Antonella Laiti, Eleonora Moretti...Pucci, Andrea Scatena, Enrico Subicini, Laura Trombi, Elisa Valenti ASL Umbria 2:...

Contenuto Web · Da admin admin Alle 27 mag 13, 02:00

I Centri Antifumo dell’Istituto Superiore Sanità salgono sui treni

Contenuto Web · Da SIMONA DEODATI Alle 13 lug 22, 23:41

A cura di Rosa Draisci, Sonia D’Ilio, Rosanna Maria Fidente, Simona Deodati, Marco...A cura di Rosa Draisci, Sonia D’Ilio, Rosanna Maria Fidente,...

Contenuto Web · Da SIMONA DEODATI Alle 22 mar 23, 10:17

nel contesto nazionale e in quello europeo – Rapporto ISTISAN 21/23 A cura di Sonia...A cura di Sonia D’Ilio, Simona Deodati, Marco Ferrari,...

Contenuto Web · Da Stefano Guderzo Alle 14 gen 20, 11:15

sicurezza d’uso e criteri di controllo – Rapporti ISTISAN 19/2 A cura di Rosa Draisci, Sonia...A cura di Rosa Draisci, Sonia D’Ilio, Rosanna Maria...

Contenuto Web · Da Antonio Arnofi Alle 19 nov 20, 16:00

, performance scolastica, e influenzare lo stato di salute in generale -spiega Sonia...PMID: 21482604 https://pubmed.ncbi.nlm.nih.gov/21482604/ Per info...

Contenuto Web · Da SIMONA DEODATI Alle 22 dic 20, 17:43

Responsabile: Sonia D’Ilio Progettazione, modellazione, sviluppo e personalizzazione...: Marco Ferrari, Stefano Guderzo, Simona Deodati Esperti: Maria Alessandrelli,...

Contenuto Web · Da ALESSANDRA FUGLIENI Alle 26 giu 23, 12:15

Filippo Monti, Alessandra Lugo, Silvano Gallus, Chiara Stival, Sabrina Molinaro, Sonia...Filippo Monti, Alessandra Lugo, Silvano Gallus, Chiara Stival, Sabrina Molinaro,...

Documento · Da admin admin Alle 4 nov 19, 16:24

ISTITUTO SUPERIORE DI SANITA’ Osservatorio Nazionale Alcol Centro Nazionale Dipendenze e Doping WORLD HEALTH ORGANIZATION Collaborating Centre for Health Promotion and Research on Alcohol and...

Contenuto Web · Da ALESSANDRA FUGLIENI Alle 2 ott 23, 11:47

Guglielmo Bonaccorsi, Patrizio Zanobini, Claudia Cosma, Primo Buscemi, Sonia Paoli...Guglielmo Bonaccorsi, Patrizio Zanobini, Claudia Cosma, Primo Buscemi,...

Contenuto Web · Da ALESSANDRA FUGLIENI Alle 2 ott 24, 12:25

Cosimo Campagni, Giuseppe Gorini, Andrea Amerio, Sonia Cerrai, Silvano Gallus, Alessandra...Cosimo Campagni, Giuseppe Gorini, Andrea Amerio, Sonia...

Contenuto Web · Da ALESSANDRA FUGLIENI Alle 30 gen 24, 10:51

Carreras, Anna Odone, Piet A van den Brandt, Giuseppe Gorini, Sabrina Molinaro, Sonia...Carreras, Anna Odone, Piet A van den Brandt, Giuseppe Gorini, Sabrina Molinaro,...

Contenuto Web · Da ALESSANDRA FUGLIENI Alle 30 gen 26, 08:58

Giuseppina Lo Moro, Maria Ferrara, Elisa Langiano, Alessandro Durbano, Sonia Pinto...Giuseppina Lo Moro, Maria Ferrara, Elisa Langiano, Alessandro Durbano,...

Documento · Da admin admin Alle 15 dic 19, 20:05

Dr.ssa Sonia D’Ilio, scadenza 10/01/2019 – Fasc. 3SO2, C.U.P....D’Ilio; RITENUTO che la dott.ssa Sonia D’Ilio, Ricercatore del Centro...

Documento · Da admin admin Alle 5 dic 19, 21:52

Rome, June 30, 2005 ABSTRACT BOOK Edited by Lucia Gabriele, Franca Moretti...Edited by Lucia Gabriele, Franca Moretti and Filippo...

Contenuto Web · Da paola tacchi venturi Alle 16 dic 21, 00:19

Per iscriversi, compilare il modulo presente al seguente link: DOMANDA DI ISCRIZIONE